We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.88%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.05B
AUM Growth
+$375M
Cap. Flow
+$361M
Cap. Flow %
34.49%
Top 10 Hldgs %
24.89%
Holding
5,677
New
1,360
Increased
1,920
Reduced
1,136
Closed
1,108

Sector Composition

Rank Sector Weight
1 Financials 6.05%
2 Technology 5.64%
3 Industrials 5.17%
4 Consumer Discretionary 4.28%
5 Healthcare 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEX icon
2476
Terex
TEX
$7.74B
$15K ﹤0.01%
715
-3,956
-85% -$90.5K
TRUP icon
2477
Trupanion
TRUP
$1.18B
$15K ﹤0.01%
1,083
+1,023
+1,705% +$13.3K
TSLX icon
2478
Sixth Street Specialty
TSLX
$1.81B
$15K ﹤0.01%
+900
New +$14.7K
TWIN icon
2479
Twin Disc
TWIN
$348M
$15K ﹤0.01%
+1,395
New +$14.7K
VHI icon
2480
Valhi
VHI
$450M
$15K ﹤0.01%
784
-1,234
-61% -$27.1K
NBIS
2481
Nebius Group N.V.
NBIS
$47.7B
$15K ﹤0.01%
+700
New +$13.6K
MAGN
2482
Magnera Corp
MAGN
$460M
$15K ﹤0.01%
58
+10
+21% +$2.69K
VSA
2483
VisionSys AI
VSA
$10.6M
$15K ﹤0.01%
+1
New +$26.6K
FBMS
2484
DELISTED
The First Bancshares, Inc.
FBMS
$15K ﹤0.01%
857
+121
+16% +$2K
ITI
2485
DELISTED
Iteris, Inc.
ITI
$15K ﹤0.01%
5,188
-595
-10% -$1.47K
TWOU
2486
DELISTED
2U Inc
TWOU
$15K ﹤0.01%
+18
New +$14.7K
BIOL
2487
DELISTED
Biolase, Inc.
BIOL
$15K ﹤0.01%
+1
New +$15.8K
PXD
2488
DELISTED
Pioneer Natural Resource Co.
PXD
$15K ﹤0.01%
+101
New +$15.8K
FSTX
2489
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$15K ﹤0.01%
+396
New +$16.9K
RFP
2490
DELISTED
Resolute Forest Products Inc.
RFP
$15K ﹤0.01%
2,760
+1,693
+159% +$9.43K
IRCP
2491
DELISTED
IRSA Propiedades Comerciales S.A.
IRCP
$15K ﹤0.01%
1,684
+1,289
+326% +$11.5K
ANAT
2492
DELISTED
American National Group, Inc. Common Stock
ANAT
$15K ﹤0.01%
133
+93
+233% +$10.8K
BMTC
2493
DELISTED
Bryn Mawr Bank Corp
BMTC
$15K ﹤0.01%
+500
New +$14K
XEC
2494
DELISTED
CIMAREX ENERGY CO
XEC
$15K ﹤0.01%
+124
New +$13.9K
SNR
2495
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$15K ﹤0.01%
1,419
+1,090
+331% +$11.6K
APEX
2496
DELISTED
Apex Global Brands Inc. Common Stock
APEX
$15K ﹤0.01%
46
+34
+283% +$15K
BLMT
2497
DELISTED
BSB Bancorp, Inc.
BLMT
$15K ﹤0.01%
665
+660
+13,200% +$15K
MSF
2498
DELISTED
Morgan Stanley Emerging Mkts Fd
MSF
$15K ﹤0.01%
1,095
+742
+210% +$9.73K
ECYT
2499
DELISTED
Endocyte, Inc. Common Stock
ECYT
$15K ﹤0.01%
4,466
+2,810
+170% +$10.3K
RSYS
2500
DELISTED
Radisys Corp
RSYS
$15K ﹤0.01%
3,285
-1,821
-36% -$8.23K

Similar funds

Tower Research Capital (TRC)'s Q2 2016 Portfolio in Review

As of Q2 2016, Tower Research Capital (TRC) held 5,677 positions worth $1.05B, up 56% from $672M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tower Research Capital (TRC) deployed $361M of net new capital in Q2 2016, opening 1,360 new positions and adding to 1,920 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 247,708 shares worth $6.21M.

By sector, the portfolio is most concentrated in Financials at 6.1% of assets, up from 2.5% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $48M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2016 buy was iShares Russell 1000 Growth ETF: 247,708 shares worth $6.21M.
  • Tower Research Capital (TRC) added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q2 2016, an estimated $24.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2016 reduction was iShares Russell 2000 ETF, cutting an estimated $48M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2016, selling an estimated $9.09M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 25% of its $1.05B portfolio in Q2 2016.
  • Tower Research Capital (TRC) opened 1,360 new positions and closed 1,108 in Q2 2016.
  • Tower Research Capital (TRC)'s portfolio value rose 56% quarter-over-quarter to $1.05B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2016, filed 10 Aug 2016.